Abstract:Subsequently to the publication of the above article, an interested reader drew to the authors' attention that Fig. 3 (showing how RACK1 silencing alters the protein expression levels of tumor malignant progress markers in OSCC in vivo) contained an overlapping data panel, such that the data were derived from the same original source where they were intending to depict the results from experiments performed under different experimental conditions and Fig. 4 (showing how RACK1 expression is positively correlated with p‑AKT in OSCC tissues and cells) contained a clearly duplicated pair of data panels. The authors were able to re‑examine their original data, and have identified the data that were intended to have been shown for these figure parts. The corrected versions of Figs. 3 and 4 are shown on the next two pages, featuring the correct data for the E‑cadherin experiments in Fig. 3B and the correct enlargement panel for the RACK1 / Moderate dysplasia experiment in Fig. 4A. The authors confirm that these inadvertent errors did not have any major impact on the conclusions reported in their paper, are grateful to the Editor of International Journal of Oncology for allowing them this opportunity to publish a Corrigendum, and apologize to the readership for any inconvenience caused. [the original article was published in International Journal of Oncology 49: 539‑548, 2016; DOI: 10.3892/ijo.2016.3562].

Author Correction: SZT2 dictates GATOR control of mTORC1 signalling

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Erratum: the FoxO–BNIP3 Axis Exerts a Unique Regulation of Mtorc1 and Cell Survival under Energy Stress

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Correction: Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway

Author Correction: Topoisomerase IIα controls the decatenation checkpoint

Correction To: TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

Erratum to: Topoisomerase IIα controls the decatenation checkpoint (Nature Cell Biology, (2009), 11, 2, (204-210), 10.1038/ncb1828)

Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

Erratum: Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers

[Corrigendum] LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells.

Correction for Lin Et Al., “protein Tyrosine Phosphatase-Like A Regulates Myoblast Proliferation and Differentiation Through MyoG and the Cell Cycling Signaling Pathway”

Correction: Corrigendum: CD95 promotes tumour growth

[Corrigendum] PRIMA‐1 met induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK‐ULK1‐Vps34 signaling cascade

Corrigendum to "Zhang Y, Han X, Hu N, Huff AF, Gao F, Ren J. Akt2 knockout alleviates prolonged caloric restriction-induced change in cardiac contractile function through regulation of autophagy. [J Mol Cell Cardiol. 2014 Jun; 71:81-91. PMID: 24368095].

ERRATUM: GH modulates hepatic epidermal growth factor signaling in the mouse

Erratum: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

Erratum to: Control of cell growth: Rag GTPases in activation of TORC1

Author Correction: Mammalian Atg8 proteins and the autophagy factor IRGM control mTOR and TFEB at a regulatory node critical for responses to pathogens

[Corrigendum] Receptor for Activated C Kinase 1 (RACK1) Promotes the Progression of OSCC Via the AKT/mTOR Pathway

Correction: Global phosphorylation analysis of ß arrestin mediated signaling downstream of a seven transmembrane receptor (7TMR)